We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.44B
AUM Growth
+$71.4M
Cap. Flow
-$5.26M
Cap. Flow %
-0.22%
Top 10 Hldgs %
47.84%
Holding
319
New
22
Increased
148
Reduced
94
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 12.77%
2 Healthcare 7.71%
3 Financials 5.22%
4 Industrials 4.55%
5 Communication Services 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
101
Mastercard
MA
$502B
$2.79M 0.11%
7,676
+112
+1% +$40.7K
EEM icon
102
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$2.63M 0.11%
66,754
-639
-0.9% -$25.4K
BND icon
103
Vanguard Total Bond Market
BND
$157B
$2.52M 0.1%
34,097
-3,976
-10% -$291K
LRGF icon
104
iShares US Equity Factor ETF
LRGF
$3.58B
$2.41M 0.1%
58,160
-153
-0.3% -$6.22K
SYK icon
105
Stryker
SYK
$125B
$2.38M 0.1%
8,349
+8
+0.1% +$2.12K
SUSA icon
106
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$2.36M 0.1%
26,928
+1,782
+7% +$153K
MRK icon
107
Merck
MRK
$322B
$2.36M 0.1%
22,192
+4,016
+22% +$434K
VIG icon
108
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.32M 0.1%
15,079
+80
+0.5% +$12.3K
TPL icon
109
Texas Pacific Land
TPL
$27.8B
$2.32M 0.09%
12,258
ITW icon
110
Illinois Tool Works
ITW
$82.6B
$2.27M 0.09%
9,314
+9
+0.1% +$2.1K
IDXX icon
111
Idexx Laboratories
IDXX
$44.1B
$2.21M 0.09%
4,417
-3
-0.1% -$1.44K
IWN icon
112
iShares Russell 2000 Value ETF
IWN
$14.3B
$2.17M 0.09%
15,827
+1,227
+8% +$178K
SCHE icon
113
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$2.09M 0.09%
85,083
-26
-0% -$644
TD icon
114
Toronto Dominion Bank
TD
$198B
$1.98M 0.08%
33,078
-99
-0.3% -$6.4K
IBM icon
115
IBM
IBM
$211B
$1.92M 0.08%
14,644
+168
+1% +$22.5K
BRK.A icon
116
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.86M 0.08%
4
HD icon
117
Home Depot
HD
$331B
$1.85M 0.08%
6,254
+327
+6% +$100K
VOE icon
118
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$1.83M 0.07%
13,640
-181
-1% -$25.1K
DIA icon
119
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$1.78M 0.07%
5,345
+505
+10% +$168K
CPNG icon
120
Coupang
CPNG
$29.3B
$1.77M 0.07%
110,838
DHR icon
121
Danaher
DHR
$137B
$1.75M 0.07%
7,838
+88
+1% +$20K
HYG icon
122
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$1.74M 0.07%
+23,034
New +$1.73M
IWF icon
123
iShares Russell 1000 Growth ETF
IWF
$121B
$1.66M 0.07%
27,240
+3,512
+15% +$202K
ESGD icon
124
iShares ESG Aware MSCI EAFE ETF
ESGD
$12B
$1.66M 0.07%
23,060
+18,944
+460% +$1.33M
JPST icon
125
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$1.64M 0.07%
32,511
-6,935,982
-100% -$349M

Similar funds

Grimes & Company's Q1 2023 Portfolio in Review

As of Q1 2023, Grimes & Company held 319 positions worth $2.44B, up 3% from $2.37B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company's Q1 2023 filing shows 22 new, 148 increased, 94 reduced and 14 closed positions. Its largest new stake was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q1 2023 buy was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 6,195,592 shares worth $154M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2023, an estimated $225M increase.
  • Grimes & Company's biggest Q1 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $349M.
  • Grimes & Company fully exited SVB Financial Group in Q1 2023, selling an estimated $5.35M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.44B portfolio in Q1 2023.
  • Grimes & Company opened 22 new positions and closed 14 in Q1 2023.
  • Grimes & Company's portfolio value rose 3% quarter-over-quarter to $2.44B.

Based on Grimes & Company's 13F filing for Q1 2023, filed 20 Apr 2023.